Forward Pharma A/S operates as a biopharmaceutical company. The company focuses on developing FP187, a proprietary formulation of dimethyl fumarate, which has been completed Phase II clinical trials used for the treatment of various inflammatory and neurological indications, including multiple sclerosis and other immune disorders, such as psoriasis. Forward Pharma A/S was founded in 2005 and is headquartered in Copenhagen, Denmark.
Industry, Sector and Symbol
Stock Exchange NASDAQ
Industry Pharmaceutical preparations
Sub-IndustryN/A
SectorMedical
SymbolNASDAQ:FWP
CUSIPN/A
Phone45-3344-4242
Debt
Debt-to-Equity RatioN/A
Current Ratio5.22
Quick Ratio5.22
Price-To-Earnings
Trailing P/E RatioN/A
Forward P/E RatioN/A
P/E GrowthN/A
Sales & Book Value
Annual Sales$1.25 billion
Price / Sales0.10
Cash Flow$19.3571 per share
Price / Cash0.14
Book Value$1.90 per share
Price / Book1.43
Profitability
EPS (Most Recent Fiscal Year)N/A
Net IncomeN/A
Net MarginsN/A
Return on EquityN/A
Return on AssetsN/A
Miscellaneous
Employees12
Outstanding Shares47,180,000
Market Cap$127.87
Forward Pharma A/S (NASDAQ:FWP) Frequently Asked Questions
What is Forward Pharma A/S's stock symbol?
Forward Pharma A/S trades on the NASDAQ under the ticker symbol "FWP."
How often does Forward Pharma A/S pay dividends? What is the dividend yield for Forward Pharma A/S?
Forward Pharma A/S announced an annual dividend on Thursday, August 24th. Shareholders of record on Thursday, September 7th will be given a dividend of $22.903 per share on Monday, September 11th. The ex-dividend date of this dividend is Wednesday, September 6th. View Forward Pharma A/S's Dividend History.
How were Forward Pharma A/S's earnings last quarter?
Forward Pharma A/S (NASDAQ:FWP) announced its quarterly earnings data on Thursday, September, 1st. The biotechnology company reported ($0.32) earnings per share (EPS) for the quarter, missing analysts' consensus estimates of ($0.26) by $0.06. View Forward Pharma A/S's Earnings History.
What price target have analysts set for FWP?
1 brokerages have issued 1 year price targets for Forward Pharma A/S's stock. Their predictions range from $6.00 to $6.00. On average, they expect Forward Pharma A/S's stock price to reach $6.00 in the next twelve months. This suggests a possible upside of 121.4% from the stock's current price. View Analyst Ratings for Forward Pharma A/S.
What is the consensus analysts' recommendation for Forward Pharma A/S?
1 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Forward Pharma A/S in the last year. There are currently 1 hold rating for the stock, resulting in a consensus recommendation of "Hold."
Who are some of Forward Pharma A/S's key competitors?
Some companies that are related to Forward Pharma A/S include Arcus Biosciences (RCUS), Rigel Pharmaceuticals (RIGL), Stemline Therapeutics (STML), Aurinia Pharmaceuticals (AUPH), Evolus (EOLS), Cytokinetics (CYTK), Forty Seven (FTSV), ZEALAND PHARMA/S (ZEAL), Lannett (LCI), Synergy Pharmaceuticals (SGYP), Verastem (VSTM), Evelo Biosciences (EVLO), Verrica Pharmaceuticals (VRCA), Zymeworks (ZYME) and Sinovac Biotech (SVA).
Who are Forward Pharma A/S's key executives?
Forward Pharma A/S's management team includes the folowing people:
- Dr. Claus Bo Svendsen M.D., Ph.D., CEO & Principal Financial Officer (Age 41)
- Mr. Thomas Carbone, Principal Accounting Officer, VP of Fin. and Controller (Age 61)
Has Forward Pharma A/S been receiving favorable news coverage?
Media coverage about FWP stock has trended somewhat positive on Sunday, according to Accern Sentiment. The research group ranks the sentiment of media coverage by reviewing more than twenty million news and blog sources in real time. Accern ranks coverage of publicly-traded companies on a scale of negative one to positive one, with scores nearest to one being the most favorable. Forward Pharma A/S earned a news impact score of 0.11 on Accern's scale. They also gave headlines about the biotechnology company an impact score of 43.70 out of 100, meaning that recent media coverage is somewhat unlikely to have an impact on the stock's share price in the immediate future.
Who are Forward Pharma A/S's major shareholders?
How do I buy shares of Forward Pharma A/S?
Shares of FWP can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.
What is Forward Pharma A/S's stock price today?
One share of FWP stock can currently be purchased for approximately $2.71.
How big of a company is Forward Pharma A/S?
Forward Pharma A/S has a market capitalization of $127.87 million and generates $1.25 billion in revenue each year. Forward Pharma A/S employs 12 workers across the globe.
How can I contact Forward Pharma A/S?
Forward Pharma A/S's mailing address is Ostergade 24A 1, COPENHAGEN G7, 1100. The biotechnology company can be reached via phone at 45-3344-4242 or via email at [email protected]
MarketBeat Community Rating for Forward Pharma A/S (NASDAQ FWP)
MarketBeat's community ratings are surveys of what our community members think about Forward Pharma A/S and other stocks. Vote "Outperform" if you believe FWP will outperform the S&P 500 over the long term. Vote "Underperform" if you believe FWP will underperform the S&P 500 over the long term. You may vote once every thirty days.
